LENNON NDI: Open Payments
NPI 1760993844 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 10 companies in 2025. Trend: 2023 $248 · 2024 $2,131 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Smith+Nephew, Inc. | 2 | $56 |
| Bioventus LLC | 2 | $45 |
| Endo USA, Inc. | 2 | $39 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Solventum Corporation | 1 | $33 |
| Orthofix Medical, Inc. | 3 | $30 |
| DePuy Synthes Sales Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Kerecis Limited | 1 | $18 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
Products named: XIAFLEX, EUFLEXXA, ACTIV.A.C., STRAVIX, Physio-Stim, DUROLANE, PICO 7, MONOVISC.
Industry payments across TX — which companies pay providers there.
